Preemies respond worse to flu, lung diseases in adulthood

Image
ANI Washington D.C. [USA]
Last Updated : Jun 09 2017 | 1:42 PM IST

A study has found that babies born before 37 weeks may respond worse to flu and other lung diseases later in life due to absence of certain lung cells.

The findings suggested when newborn mices are exposed to extra oxygen at birth, which causes their lungs to respond and develop similarly to those of preterm infants, they end up with far fewer of these cells once they reach adulthood.

The University of Rochester Medical Center in the US researchers explained that mice born into an oxygen-rich environment respond worse to the flu once fully grown due to an absence of certain lung cells, a discovery that provides a potential explanation for preterm infants' added susceptibility to influenza and other lung diseases later in their lives.

The research focuses on alveolar type II cells, which help to rebuild lung tissue after damage.

Once exposed to influenza virus as adults, these mice then developed a much more severe disease than mice born in a traditional oxygen environment.

"We don't know if this is exactly what happens in preterm infants," said Michael O'Reilly.

"But we do know that there's a direct correlation between the loss of these cells and an inferior response to lung disease and we do know that there's something about that early oxygen-rich environment that causes a mouse to respond poorly to viral infection later in life. So this helps connect those dots," O'Reilly added.

The cells are abundant in the lungs of healthy infants, as they are responsible for producing pulmonary surfactant - a vital compound for the developing lung.

As the lungs mature after birth, some of these cells may be pruned away. In theory, the lungs of premature infants take this process too far, pruning too many type II cells.

"Right now, we don't really understand the biology of that," said O'Reilly. "But once we do, that opens the door to exploring a potential treatment."

The study is published in the Journal of Respiratory Cell and Molecular Biology.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 09 2017 | 1:17 PM IST

Next Story